The drugging of the Americas
how multinational drug companies say one thing about their products to physicians in the United States, and another thing to physicians in Latin America
Our rough guess is there are 36,750 words in this book.
At a pace averaging 250 words per minute, this book will take 2 hours and 27 minutes to read. With a half hour per day, this will take 5 days to read.
How long will it take you?
This book will take an estimated to read at a reading speed averaging words per minute. With 30 minutes per day, this will take to read.
Enter your reading speedYou can take one of our WPM reading speed tests to find your reading speed.
Create a free account to track your reading progress, build your reading list, and set reading goals.
Author
Publication
1976 - University of California Press, Berkeley, California
Language
English
Word Count
36,750 words, Guess
Page Count
147 pages
Identifiers
- Open LibraryOL5203089M
- OCLC Control Number2277688
- OCLC Control Numberdruggingofameric0000silv
- Library of Congress Control Number75027935
Classifications
- DDC614.3/5/098
- LCCRM301 .S53
Description
In the United States, drug companies promoting their products to physicians are required by law to limit their claims to what they can prove, and to make full disclosure of all known hazards. Dr. Silverman, a noted science writer and pharmacologist, finds that many multinational drug companies are circumventing similar laws in Latin America in order to sell more of their products. The author provides detailed comparisons of the promotion of 28 separate prescription drugs in the U.S. and in Mexico, Central America, and other Latin American countries. Typically, claims for effectiveness are exaggerated in Latin America and the hazards are glossed over. This practice, denounced by Latin American medical experts and appalling even to scientists within the drug industry, is blamed for needless patient injury and death. When called upon to explain the inconsistencies in their promotional campaigns, their standard defense is "we're not breaking any laws." But some of these global companies have been breaking laws. They have been lying. In the United States, the major pharmaceutical companies have long and vociferously assailed the laws which now require them to restrict claims of efficacy of their products to those they can support with substantial scientific evidence and to inform physicians fully of all hazards. The companies argue that these rules are excessively harsh and that these laws and regulations are not necessary because the industry recognizes its social responsibilities and would live up to them, laws or no laws. The information presented here is a partial response to such an argument. It demonstrates that a problem exists and shows how some companies comport themselves when there are no restrictive laws, or when the laws are not enforced. -- from Preface.
Subjects
Topics
Places
Other Editions
- The drugging of the Americas: how multinational drug companies say one thing about their products to physicians in the United States, and another thing to physicians in Latin America
Similar Books
The Truth About the Drug Companies: How They Deceive Us and What to Do About It
Marcia Angell
Pharmacoepidemiology
Brian L. Strom, Stephen E. Kimmel, Sean Hennessy
Living With Drugs
Michael Gossop
Drug-induced liver disease
edited by Neil Kaplowitz, Laurie D. DeLeve.
Adverse drug effects: a nursing concern
Jennifer Kelly.
Reader Reviews
No reviews yet for this book.
Be the first to share your thoughts!